# Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU

> **NCT02723383** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 314 (actual)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** BACLOFEN
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT02723383
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-27
- **Primary completion:** 2019-08-14
- **Final completion:** 2019-08-14
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2020-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02723383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02723383, "Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02723383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*